HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 201 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $1,340,000 | -44.1% | 33,600 | -36.3% | 0.00% | -50.0% |
Q2 2021 | $2,396,000 | +17.9% | 52,766 | -58.2% | 0.00% | 0.0% |
Q1 2019 | $2,032,000 | +1538.7% | 126,200 | +1385.8% | 0.00% | – |
Q4 2018 | $124,000 | -81.6% | 8,494 | -78.8% | 0.00% | -100.0% |
Q2 2018 | $675,000 | -95.5% | 40,000 | -94.8% | 0.00% | -95.0% |
Q1 2018 | $14,957,000 | +66.8% | 763,500 | +72.4% | 0.02% | +53.8% |
Q4 2017 | $8,969,000 | -12.0% | 442,770 | -24.6% | 0.01% | -23.5% |
Q3 2017 | $10,197,000 | +377.4% | 587,000 | +252.3% | 0.02% | +325.0% |
Q2 2017 | $2,136,000 | -0.7% | 166,600 | +0.4% | 0.00% | -20.0% |
Q1 2017 | $2,151,000 | +222.5% | 165,929 | +145.8% | 0.01% | +400.0% |
Q4 2016 | $667,000 | -69.1% | 67,500 | -73.0% | 0.00% | -75.0% |
Q2 2016 | $2,158,000 | -40.5% | 250,000 | -34.7% | 0.00% | -50.0% |
Q1 2016 | $3,628,000 | +719.0% | 383,100 | +1060.9% | 0.01% | +700.0% |
Q3 2015 | $443,000 | -83.8% | 33,000 | -72.8% | 0.00% | -83.3% |
Q2 2015 | $2,739,000 | +593.4% | 121,300 | +203.2% | 0.01% | +200.0% |
Q2 2014 | $395,000 | – | 40,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Security, LLC | 19,305,403 | $233,209,000 | 10.86% |
BB BIOTECH AG | 7,379,832 | $89,148,000 | 3.13% |
SENZAR ASSET MANAGEMENT, LLC | 550,544 | $6,650,572,000 | 1.72% |
SNYDER CAPITAL MANAGEMENT L P | 2,232,114 | $26,964,000 | 1.69% |
Sterling Global Strategies LLC | 22,000 | $266,000 | 0.98% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 9,290,024 | $112,223,000 | 0.98% |
MSD Partners, L.P. | 965,000 | $11,657,000 | 0.94% |
DOHENY ASSET MANAGEMENT /CA | 130,950 | $1,582,000 | 0.81% |
Taylor Wealth Management Partners | 128,110 | $1,548,000 | 0.69% |
Bellevue Group AG | 318,000 | $3,841,000 | 0.69% |